Phytohealth Corp Market Cap ($71.02 Million)
Market Cap & Net Worth: Phytohealth Corp (4108)
Phytohealth Corp market cap. Phytohealth Corp (TW:4108) has a market capitalization of $71.02 Million (NT$2.25 Billion) as of October 31, 2026. Listed on the TW stock exchange, this Taiwan-based company holds position #20416 globally and #1226 in its home market, demonstrating a 2.25% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Phytohealth Corp's stock price NT$11.35 by its total outstanding shares 198619000 (198.62 Million).
Phytohealth Corp Market Cap History (2015–2026)
Phytohealth Corp market cap history from 2015 to 2026. Data shows change from $169.02 Million to $71.02 Million (-8.18% CAGR). Check latest Phytohealth Corp stock price today for real-time trading data and today's change.
Phytohealth Corp Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Phytohealth Corp's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Also see Phytohealth Corp operating cash flow efficiency for how efficiently the company converts equity into cash flow.
Latest Price to Sales (P/S) Ratio
0.63x
Phytohealth Corp's market cap is 0.63 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $185.40 Million | $25.02 Million | -$194.52 Million | 7.41x | N/A |
| 2017 | $141.10 Million | $54.00 Million | -$206.35 Million | 2.61x | N/A |
| 2018 | $109.85 Million | $107.48 Million | -$182.48 Million | 1.02x | N/A |
| 2019 | $109.24 Million | $95.48 Million | -$170.93 Million | 1.14x | N/A |
| 2020 | $153.54 Million | $91.81 Million | -$118.66 Million | 1.67x | N/A |
| 2021 | $145.80 Million | $168.94 Million | -$78.02 Million | 0.86x | N/A |
| 2022 | $119.52 Million | $135.47 Million | -$115.03 Million | 0.88x | N/A |
| 2023 | $135.79 Million | $162.49 Million | -$47.12 Million | 0.84x | N/A |
| 2024 | $105.13 Million | $153.56 Million | -$73.50 Million | 0.68x | N/A |
| 2025 | $84.48 Million | $134.58 Million | -$58.20 Million | 0.63x | N/A |
Competitor Companies of 4108 by Market Capitalization
Companies near Phytohealth Corp in the global market cap rankings as of October 31, 2026. See Phytohealth Corp (4108) balance sheet quality index to understand what proportion of total assets are financed by equity.
Key companies related to Phytohealth Corp by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #515 globally with a market cap of $52.60 Billion USD.
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #536 globally with a market cap of $50.42 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #600 globally with a market cap of $45.38 Billion USD ( CN¥310.15 Billion CNY).
- Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #626 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #515 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #536 | GALDERMA GROUP AG | NYSE:GALDY | $50.42 Billion | $45.98 |
| #600 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $45.38 Billion | CN¥48.62 |
| #626 | Takeda Pharmaceutical Company Limited | F:TKDA | $43.60 Billion | €17.90 |
Market Capitalization of Phytohealth Corp (2015–2026)
Market capitalization of Phytohealth Corp from 2015 to today. Between 2015 and today, Phytohealth Corp's market cap moved from $169.02 Million to $ 71.02 Million, with a yearly change of -8.18%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | NT$71.02 Million | -15.93% |
| 2025 | NT$84.48 Million | -19.64% |
| 2024 | NT$105.13 Million | -22.58% |
| 2023 | NT$135.79 Million | +13.61% |
| 2022 | NT$119.52 Million | -18.03% |
| 2021 | NT$145.80 Million | -5.04% |
| 2020 | NT$153.54 Million | +40.55% |
| 2019 | NT$109.24 Million | -0.55% |
| 2018 | NT$109.85 Million | -22.15% |
| 2017 | NT$141.10 Million | -23.89% |
| 2016 | NT$185.40 Million | +9.69% |
| 2015 | NT$169.02 Million | -- |
End of Day Market Cap According to Different Sources
On Oct 30th, 2026 the market cap of Phytohealth Corp was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $71.02 Million USD |
| MoneyControl | $71.02 Million USD |
| MarketWatch | $71.02 Million USD |
| marketcap.company | $71.02 Million USD |
| Reuters | $71.02 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Phytohealth Corp
PhytoHealth Corporation researches, develops, manufactures, and sells medicines, cosmetics, Class B medicines, complementary foods, and other related products in Taiwan. It operates in three segments: Medicines and Health Food, Medical Diagnosis, and Precision Medical Equipment and Instruments. The Medicines and Health Food segment manufactures and sells Chinese medicine materials and new drugs. … Read more